Protein family
The protein has not catalytic activity
Protein sequence
Protein function
Catalytic activity
| PDB | Resolution (Å) | PDB name |
|---|---|---|
| 1AXC | 2.6 | HUMAN PCNA |
| 2ZVV | 2.0 | Crystal structure of Proliferating cellular nuclear antigen 1 and Short peptide from human P21 |
| 2ZVW | 2.5 | Crystal structure of Proliferating cell nuclear antigen 2 and Short peptide from human P21 |
| 4RJF | 2.0072 | Crystal structure of the human sliding clamp at 2.0 angstrom resolution |
| 5E0U | 1.93 | Human PCNA variant (S228I) complexed with p21 at 1.9 Angstroms |
| 6CBI | 2.75 | PCNA in complex with inhibitor |
| 6CEJ | Solution structure of a 14mer fragment of the p21 protein | |
| 6CIV | Lactam cyclised mimetic of a fragment of p21 | |
| 6CIX | Lactam cyclised mimetic of a fragment of p21 | |
| 6P8H | 3.19 | Crystal structure of CDK4 in complex with CyclinD1 and P21 |
| 7KQ0 | 2.4 | PCNA bound to peptide mimetic |
| 7KQ1 | 3.3 | PCNA bound to truncated peptide mimetic |
| GO ontology
|
GO term | GO description |
|---|---|---|
| Biological Process | GO:0006974 | DNA damage response |
| Biological Process | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest |
| Biological Process | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator |
| Biological Process | GO:0000082 | G1/S transition of mitotic cell cycle |
| Biological Process | GO:0007265 | Ras protein signal transduction |
| Biological Process | GO:0071493 | cellular response to UV-B |
| Biological Process | GO:0034198 | cellular response to amino acid starvation |
| Biological Process | GO:0031668 | cellular response to extracellular stimulus |
| Biological Process | GO:0071480 | cellular response to gamma radiation |
| Biological Process | GO:0071479 | cellular response to ionizing radiation |
| Biological Process | GO:0090398 | cellular senescence |
| Biological Process | GO:0007507 | heart development |
| Biological Process | GO:0097193 | intrinsic apoptotic signaling pathway |
| Biological Process | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
| Biological Process | GO:0030216 | keratinocyte differentiation |
| Biological Process | GO:0043616 | keratinocyte proliferation |
| Biological Process | GO:0007095 | mitotic G2 DNA damage checkpoint signaling |
| Biological Process | GO:2000279 | negative regulation of DNA biosynthetic process |
| Biological Process | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle |
| Biological Process | GO:1905179 | negative regulation of cardiac muscle tissue regeneration |
| Biological Process | GO:0030308 | negative regulation of cell growth |
| Biological Process | GO:0008285 | negative regulation of cell population proliferation |
| Biological Process | GO:1904030 | negative regulation of cyclin-dependent protein kinase activity |
| Biological Process | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity |
| Biological Process | GO:0010629 | negative regulation of gene expression |
| Biological Process | GO:0042326 | negative regulation of phosphorylation |
| Biological Process | GO:0032091 | negative regulation of protein binding |
| Biological Process | GO:0001933 | negative regulation of protein phosphorylation |
| Biological Process | GO:1904706 | negative regulation of vascular associated smooth muscle cell proliferation |
| Biological Process | GO:0090402 | oncogene-induced cell senescence |
| Biological Process | GO:0030890 | positive regulation of B cell proliferation |
| Biological Process | GO:0048146 | positive regulation of fibroblast proliferation |
| Biological Process | GO:0043068 | positive regulation of programmed cell death |
| Biological Process | GO:0045860 | positive regulation of protein kinase activity |
| Biological Process | GO:0001934 | positive regulation of protein phosphorylation |
| Biological Process | GO:2000379 | positive regulation of reactive oxygen species metabolic process |
| Biological Process | GO:0006606 | protein import into nucleus |
| Biological Process | GO:2000045 | regulation of G1/S transition of mitotic cell cycle |
| Biological Process | GO:0010389 | regulation of G2/M transition of mitotic cell cycle |
| Biological Process | GO:0051726 | regulation of cell cycle |
| Biological Process | GO:1902806 | regulation of cell cycle G1/S phase transition |
| Biological Process | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity |
| Biological Process | GO:0090399 | replicative senescence |
| Biological Process | GO:0090400 | stress-induced premature senescence |
| Biological Process | GO:0042246 | tissue regeneration |
| Biological Process | GO:0042060 | wound healing |
| Molecular Function | GO:0030332 | cyclin binding |
| Molecular Function | GO:0019912 | cyclin-dependent protein kinase activating kinase activity |
| Molecular Function | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity |
| Molecular Function | GO:0046872 | metal ion binding |
| Molecular Function | GO:0140677 | molecular function activator activity |
| Molecular Function | GO:0140678 | molecular function inhibitor activity |
| Molecular Function | GO:0019901 | protein kinase binding |
| Molecular Function | GO:0004860 | protein kinase inhibitor activity |
| Molecular Function | GO:0140311 | protein sequestering activity |
| Molecular Function | GO:0044877 | protein-containing complex binding |
| Molecular Function | GO:0031625 | ubiquitin protein ligase binding |
| Cellular Component | GO:0070557 | PCNA-p21 complex |
| Cellular Component | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex |
| Cellular Component | GO:0005829 | cytosol |
| Cellular Component | GO:0016604 | nuclear body |
| Cellular Component | GO:0005730 | nucleolus |
| Cellular Component | GO:0005654 | nucleoplasm |
| Cellular Component | GO:0005634 | nucleus |
| Cellular Component | GO:0032991 | protein-containing complex |
| Reactome
|
Reactome Name | Node type
|
Reactome Root | Reactome Root Name |
|---|---|---|---|---|
| R-HSA-187577 | SCF(Skp2)-mediated degradation of p27/p21 | Leaf | R-HSA-1640170 | Cell Cycle |
| R-HSA-198323 | AKT phosphorylates targets in the cytosol | Leaf | R-HSA-162582 | Signal Transduction |
| R-HSA-2559582 | Senescence-Associated Secretory Phenotype (SASP) | Leaf | R-HSA-8953897 | Cellular responses to stimuli |
| R-HSA-2559586 | DNA Damage/Telomere Stress Induced Senescence | Internal node | R-HSA-8953897 | Cellular responses to stimuli |
| R-HSA-5674400 | Constitutive Signaling by AKT1 E17K in Cancer | Leaf | R-HSA-1643685 | Disease |
| R-HSA-6785807 | Interleukin-4 and Interleukin-13 signaling | Leaf | R-HSA-168256 | Immune System |
| R-HSA-6804116 | TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | Leaf | R-HSA-74160 | Gene expression (Transcription) |
| R-HSA-69202 | Cyclin E associated events during G1/S transition | Internal node | R-HSA-1640170 | Cell Cycle |
| R-HSA-69231 | Cyclin D associated events in G1 | Internal node | R-HSA-1640170 | Cell Cycle |
| R-HSA-69563 | p53-Dependent G1 DNA Damage Response | Internal node | R-HSA-1640170 | Cell Cycle |
| R-HSA-69656 | Cyclin A:Cdk2-associated events at S phase entry | Internal node | R-HSA-1640170 | Cell Cycle |
| R-HSA-69895 | Transcriptional activation of cell cycle inhibitor p21 | Leaf | R-HSA-1640170 | Cell Cycle |
| R-HSA-8852276 | The role of GTSE1 in G2/M progression after G2 checkpoint | Leaf | R-HSA-1640170 | Cell Cycle |
| R-HSA-8866911 | TFAP2 (AP-2) family regulates transcription of cell cycle factors | Leaf | R-HSA-74160 | Gene expression (Transcription) |
| R-HSA-8878166 | Transcriptional regulation by RUNX2 | Internal node | R-HSA-74160 | Gene expression (Transcription) |
| R-HSA-8941855 | RUNX3 regulates CDKN1A transcription | Leaf | R-HSA-74160 | Gene expression (Transcription) |
| R-HSA-8951664 | Neddylation | Leaf | R-HSA-392499 | Metabolism of proteins |
| R-HSA-9616222 | Transcriptional regulation of granulopoiesis | Leaf | R-HSA-1266738 | Developmental Biology |
| R-HSA-9617828 | FOXO-mediated transcription of cell cycle genes | Leaf | R-HSA-74160 | Gene expression (Transcription) |
| R-HSA-9661069 | Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | Leaf | R-HSA-1643685 | Disease |
| R-HSA-9702518 | STAT5 activation downstream of FLT3 ITD mutants | Leaf | R-HSA-1643685 | Disease |
| R-HSA-9703465 | Signaling by FLT3 fusion proteins | Leaf | R-HSA-1643685 | Disease |
| R-HSA-9755511 | KEAP1-NFE2L2 pathway | Internal node | R-HSA-8953897 | Cellular responses to stimuli |
| Location
|
ECO term
|
Pubmed |
|---|---|---|
| Cytoplasm | ECO:0000269 | PubMed:11463845 |
| Nucleus | ECO:0000269 | PubMed:11463845 |
| Nucleus | ECO:0000269 | PubMed:23213251 |
| HPO ID
|
HPO name |
|---|---|
| HP:0000141 | Amenorrhea |
| HP:0000169 | Gingival fibromatosis |
| HP:0000716 | Depression |
| HP:0000736 | Short attention span |
| HP:0000787 | Nephrolithiasis |
| HP:0000802 | Impotence |
| HP:0000822 | Hypertension |
| HP:0000845 | Elevated circulating growth hormone concentration |
| HP:0000849 | Adrenocortical abnormality |
| HP:0000853 | Goiter |
| HP:0001012 | Multiple lipomas |
| HP:0001254 | Lethargy |
| HP:0001259 | Coma |
| HP:0001289 | Confusion |
| HP:0001293 | Cranial nerve compression |
| HP:0001579 | Primary hypercortisolism |
| HP:0001824 | Weight loss |
| HP:0001944 | Dehydration |
| HP:0002013 | Vomiting |
| HP:0002014 | Diarrhea |
| HP:0002018 | Nausea |
| HP:0002019 | Constipation |
| HP:0002020 | Gastroesophageal reflux |
| HP:0002027 | Abdominal pain |
| HP:0002039 | Anorexia |
| HP:0002044 | Zollinger-Ellison syndrome |
| HP:0002150 | Hypercalciuria |
| HP:0002248 | Hematemesis |
| HP:0002249 | Melena |
| HP:0002315 | Headache |
| HP:0002588 | Duodenal ulcer |
| HP:0002659 | Increased susceptibility to fractures |
| HP:0002666 | Pheochromocytoma |
| HP:0002797 | Osteolysis |
| HP:0002858 | Meningioma |
| HP:0002888 | Ependymoma |
| HP:0002890 | Thyroid carcinoma |
| HP:0002893 | Pituitary adenoma |
| HP:0002894 | Neoplasm of the pancreas |
| HP:0003072 | Hypercalcemia |
| HP:0003118 | Increased circulating cortisol level |
| HP:0003144 | Increased serum serotonin |
| HP:0003528 | Elevated calcitonin |
| HP:0004349 | Reduced bone mineral density |
| HP:0004398 | Peptic ulcer |
| HP:0005605 | Large cafe-au-lait macules with irregular margins |
| HP:0006723 | Intestinal carcinoid |
| HP:0006744 | Adrenocortical carcinoma |
| HP:0006767 | Pituitary prolactin cell adenoma |
| HP:0006780 | Parathyroid carcinoma |
| HP:0007449 | Confetti-like hypopigmented macules |
| HP:0008200 | Primary hyperparathyroidism |
| HP:0008208 | Parathyroid hyperplasia |
| HP:0008291 | Pituitary corticotropic cell adenoma |
| HP:0010615 | Angiofibromas |
| HP:0011151 | Atypical absence status epilepticus |
| HP:0011407 | Proportionate tall stature |
| HP:0011759 | Pituitary gonadotropic cell adenoma |
| HP:0011760 | Pituitary growth hormone cell adenoma |
| HP:0011761 | Pituitary null cell adenoma |
| HP:0011762 | Pituitary thyrotropic cell adenoma |
| HP:0012197 | Insulinoma |
| HP:0012232 | Shortened QT interval |
| HP:0030404 | Glucagonoma |
| HP:0030405 | Pancreatic endocrine tumor |
| HP:0030445 | Pulmonary carcinoid tumor |
| HP:0031058 | Impairment of activities of daily living |
| HP:0032044 | Decreased vigilance |
| HP:0040085 | Abnormal circulating aldosterone |
| HP:0040306 | Decreased male libido |
| HP:0100522 | Thymoma |
| HP:0100570 | Carcinoid tumor |
| HP:0100829 | Galactorrhea |
| HP:0500167 | Hypergastrinemia |